Beijing Microstructure Factory Biotechnology
Has been focusing on providing high-quality, convenient and reliable products and services for life science research.
Launch date
Market cap
-
Enterprise valuation
€48—71m (Dealroom.co estimates Nov 2022.)
China (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | CNY95.0m | Series A | |
| Total Funding | €11.9m | ||